These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 25680514)

  • 21. Human ovarian tumour-derived chaperone-rich cell lysate (CRCL) elicits T cell responses in vitro.
    Li G; Zeng Y; Chen X; Larmonier N; Sepassi M; Graner MW; Andreansky S; Brewer MA; Katsanis E
    Clin Exp Immunol; 2007 Apr; 148(1):136-45. PubMed ID: 17349014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cells pulsed with tumor extract-cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor.
    Aoki H; Mizuno M; Natsume A; Tsugawa T; Tsujimura K; Takahashi T; Yoshida J
    Cancer Immunol Immunother; 2001 Nov; 50(9):463-8. PubMed ID: 11761440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma.
    Jiang XB; Lu XL; Hu P; Liu RE
    Vaccine; 2009 Oct; 27(44):6210-6. PubMed ID: 19699331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-derived, chaperone-rich cell lysate activates dendritic cells and elicits potent antitumor immunity.
    Zeng Y; Feng H; Graner MW; Katsanis E
    Blood; 2003 Jun; 101(11):4485-91. PubMed ID: 12576309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor mRNA-loaded dendritic cells elicit tumor-specific CD8(+) cytotoxic T cells in patients with malignant glioma.
    Kobayashi T; Yamanaka R; Homma J; Tsuchiya N; Yajima N; Yoshida S; Tanaka R
    Cancer Immunol Immunother; 2003 Oct; 52(10):632-7. PubMed ID: 12827308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma.
    Hömberg N; Adam C; Riedel T; Brenner C; Flatley A; Röcken M; Mocikat R
    Int J Cancer; 2014 Dec; 135(12):2825-33. PubMed ID: 24771135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancement of DC vaccine potency by activating the PI3K/AKT pathway with a small interfering RNA targeting PTEN.
    Kim JH; Kang TH; Noh KH; Kim SH; Lee YH; Kim KW; Bae HC; Ahn YH; Choi EY; Kim JS; Lee KM; Kim TW
    Immunol Lett; 2010 Nov; 134(1):47-54. PubMed ID: 20727912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly(I:C) enhanced anti-cervical cancer immunities induced by dendritic cells-derived exosomes.
    Chen S; Lv M; Fang S; Ye W; Gao Y; Xu Y
    Int J Biol Macromol; 2018 Jul; 113():1182-1187. PubMed ID: 29427678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor efficacy of argon-helium cryoablation-generated dendritic cell vaccine in glioma.
    Yin Z; Lu G; Xiao Z; Liu T; He X; Wang Q; Lin C; Zhang S
    Neuroreport; 2014 Mar; 25(4):199-204. PubMed ID: 24445619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Lymphocyte Subsets in the Immune Response to Primary B Cell-Derived Exosomes.
    Saunderson SC; McLellan AD
    J Immunol; 2017 Oct; 199(7):2225-2235. PubMed ID: 28842467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells.
    Smith KE; Fritzell S; Badn W; Eberstål S; Janelidze S; Visse E; Darabi A; Siesjö P
    Int J Cancer; 2009 Feb; 124(3):630-7. PubMed ID: 18972433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes.
    He XZ; Wang QF; Han S; Wang HQ; Ye YY; Zhu ZY; Zhang SZ
    Drug Des Devel Ther; 2015; 9():1449-58. PubMed ID: 25792805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of interferon-alpha transfected dendritic cells into central nervous system tumors enhances the antitumor efficacy of peripheral peptide-based vaccines.
    Okada H; Tsugawa T; Sato H; Kuwashima N; Gambotto A; Okada K; Dusak JE; Fellows-Mayle WK; Papworth GD; Watkins SC; Chambers WH; Potter DM; Storkus WJ; Pollack IF
    Cancer Res; 2004 Aug; 64(16):5830-8. PubMed ID: 15313927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cord blood stem-cell-derived dendritic cells generate potent antigen-specific immune responses and anti-tumour effects.
    Chang MC; Lee CN; Chen YL; Chiang YC; Sun WZ; Hu YH; Chen CA; Cheng WF
    Clin Sci (Lond); 2012 Sep; 123(6):347-60. PubMed ID: 22264240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of STAT3 promotes the efficacy of adoptive transfer therapy using type-1 CTLs by modulation of the immunological microenvironment in a murine intracranial glioma.
    Fujita M; Zhu X; Sasaki K; Ueda R; Low KL; Pollack IF; Okada H
    J Immunol; 2008 Feb; 180(4):2089-98. PubMed ID: 18250414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A combination of exosomes carrying TSA derived from HLA-A2-positive human white buffy coat and polyI:C for use as a subcellular antitumor vaccination.
    Ren WN; Chang CK; Fan HH; Guo F; Ren YN; Yang J; Guo J; Li X
    J Immunoassay Immunochem; 2011; 32(3):207-18. PubMed ID: 21574092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glioma stem cell-targeted dendritic cells as a tumor vaccine against malignant glioma.
    Ji B; Chen Q; Liu B; Wu L; Tian D; Guo Z; Yi W
    Yonsei Med J; 2013 Jan; 54(1):92-100. PubMed ID: 23225804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas.
    Pellegatta S; Poliani PL; Corno D; Menghi F; Ghielmetti F; Suarez-Merino B; Caldera V; Nava S; Ravanini M; Facchetti F; Bruzzone MG; Finocchiaro G
    Cancer Res; 2006 Nov; 66(21):10247-52. PubMed ID: 17079441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-tumoral dendritic cells increase efficacy of peripheral vaccination by modulation of glioma microenvironment.
    Pellegatta S; Poliani PL; Stucchi E; Corno D; Colombo CA; Orzan F; Ravanini M; Finocchiaro G
    Neuro Oncol; 2010 Apr; 12(4):377-88. PubMed ID: 20308315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 70-kDa heat shock protein coated magnetic nanocarriers as a nanovaccine for induction of anti-tumor immune response in experimental glioma.
    Shevtsov MA; Nikolaev BP; Yakovleva LY; Parr MA; Marchenko YY; Eliseev I; Yudenko A; Dobrodumov AV; Zlobina O; Zhakhov A; Ischenko AM; Pitkin E; Multhoff G
    J Control Release; 2015 Dec; 220(Pt A):329-340. PubMed ID: 26522072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.